Exploring the Future of Cancer Diagnostics: Insights from the 2025 AVBCC Summit Cizzle Bio's CEO, Bill Behnke, moderated a key panel focused on innovative cancer diagnostics at the 2025 AVBCC Summit, addressing critical topics in oncology.

Exploring the Future of Cancer Diagnostics: Insights from the 2025 AVBCC Summit #United_States #New_York #Cizzle_Bio #Bill_Behnke #AVBCC_Summit